E-cigarettes have been touted as a way to help people stop using combustible cigarettes, but a new analysis in the Annals of Internal Medicine estimates 1.9 million American adults who vape have never smoked tobacco cigarettes.

Socioeconomic factors—namely a mother’s insurance status and level of education—weigh heavily on Hispanic infants’ chances of surviving critical congenital heart disease (CHD) in their first year of life, a study out of the University of California, San Francisco suggests.

MRI measurements of carotid wall thickness improve predictions of cardiovascular disease risk more than a commonly used ultrasound-based test, according to research published Oct. 9 in Radiology.

Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a meta-analysis published in the Journal of the American College of Cardiology.

In spite of recent research suggesting statins might carry some benefit for non-CVD patients, a review published in the Annals of Internal Medicine this week concluded they have no role outside of heart disease and could, in some cases, even increase patients’ risk for diabetes and myopathy.

For the first time, the World Health Organization (WHO) has included ambient noise from leisure-time activities in its guidelines on how cumulative exposure to high volumes can lead to health problems, including stress, hypertension and heart disease.

MINNEAPOLIS, Oct. 10, 2018 – Cardialen, Inc., a medical device company developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm, announced today the closing of a $17 million Series B investment led by RiverVest Venture Partners, along with Qiming Venture Partners, HBM Healthcare Investments and Cultivation Capital.

A genomic risk prediction tool developed by researchers in Australia and the U.K. has achieved greater risk discrimination than its predecessors while identifying patients at the highest and lowest likelihood of developing coronary artery disease (CAD), according to a study published ahead of print in the Journal of the American College of Cardiology.

When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new study in the Journal of the American College of Cardiology. But those visits occur less often for that subgroup of patients than in AFib patients without cancer.

Rapidly growing rates of obesity and diabetes—already threats to global health—will likely have fatal consequences in the case of a future flu pandemic, the Telegraph reported this week.